Spinal Fluid Biomarkers Detect Neurodegeneration and Alzheimer's Disease in Living Patients

Researchers report Alzheimer's disease and other neurodegenerative disorders can be confirmed in living patients by specific biomarkers in cerebrospinal fluid.